エーザイの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/01/20 | 4,251 | 4,275 | 4,226 | 4,226 | -14 | -0.3% | 574,000 |
| 2025/01/17 | 4,220 | 4,252 | 4,195 | 4,240 | +18 | +0.4% | 978,700 |
| 2025/01/16 | 4,250 | 4,312 | 4,222 | 4,222 | +10 | +0.2% | 1,410,500 |
| 2025/01/15 | 4,297 | 4,310 | 4,207 | 4,212 | -71 | -1.7% | 1,233,000 |
| 2025/01/14 | 4,248 | 4,287 | 4,221 | 4,283 | +24 | +0.6% | 1,576,000 |
| 2025/01/10 | 4,382 | 4,395 | 4,257 | 4,259 | -116 | -2.7% | 1,658,800 |
| 2025/01/09 | 4,350 | 4,380 | 4,323 | 4,375 | +17 | +0.4% | 1,174,600 |
| 2025/01/08 | 4,425 | 4,441 | 4,352 | 4,358 | -56 | -1.3% | 1,199,900 |
| 2025/01/07 | 4,390 | 4,433 | 4,352 | 4,414 | +43 | +1% | 1,443,900 |
| 2025/01/06 | 4,339 | 4,376 | 4,306 | 4,371 | +42 | +1% | 1,536,400 |
| 2024/12/30 | 4,326 | 4,387 | 4,302 | 4,329 | -26 | -0.6% | 1,372,300 |
| 2024/12/27 | 4,274 | 4,364 | 4,270 | 4,355 | +131 | +3.1% | 2,340,700 |
| 2024/12/26 | 4,274 | 4,293 | 4,221 | 4,224 | -53 | -1.2% | 3,239,400 |
| 2024/12/25 | 4,268 | 4,281 | 4,238 | 4,277 | +19 | +0.4% | 1,189,000 |
| 2024/12/24 | 4,275 | 4,334 | 4,257 | 4,258 | -15 | -0.4% | 2,006,900 |
| 2024/12/23 | 4,324 | 4,325 | 4,242 | 4,273 | -43 | -1% | 1,403,900 |
| 2024/12/20 | 4,360 | 4,391 | 4,316 | 4,316 | -23 | -0.5% | 2,114,400 |
| 2024/12/19 | 4,331 | 4,370 | 4,328 | 4,339 | -11 | -0.3% | 1,149,400 |
| 2024/12/18 | 4,380 | 4,382 | 4,334 | 4,350 | +5 | +0.1% | 998,000 |
| 2024/12/17 | 4,325 | 4,370 | 4,318 | 4,345 | -3 | -0.1% | 1,065,300 |
| 2024/12/16 | 4,385 | 4,388 | 4,323 | 4,348 | -33 | -0.8% | 1,022,900 |
| 2024/12/13 | 4,370 | 4,416 | 4,357 | 4,381 | -59 | -1.3% | 1,983,300 |
| 2024/12/12 | 4,441 | 4,488 | 4,417 | 4,440 | +5 | +0.1% | 1,464,500 |
| 2024/12/11 | 4,428 | 4,458 | 4,396 | 4,435 | +17 | +0.4% | 1,275,300 |
| 2024/12/10 | 4,495 | 4,501 | 4,402 | 4,418 | -52 | -1.2% | 1,721,900 |
| 2024/12/09 | 4,474 | 4,523 | 4,442 | 4,470 | +8 | +0.2% | 2,215,900 |
| 2024/12/06 | 4,452 | 4,485 | 4,441 | 4,462 | +10 | +0.2% | 1,324,000 |
| 2024/12/05 | 4,555 | 4,558 | 4,440 | 4,452 | -62 | -1.4% | 1,617,200 |
| 2024/12/04 | 4,581 | 4,581 | 4,392 | 4,514 | -165 | -3.5% | 2,844,600 |
| 2024/12/03 | 4,650 | 4,693 | 4,640 | 4,679 | +38 | +0.8% | 1,131,700 |
| 2024/12/02 | 4,680 | 4,716 | 4,612 | 4,641 | -29 | -0.6% | 923,400 |
| 2024/11/29 | 4,633 | 4,698 | 4,622 | 4,670 | +8 | +0.2% | 911,300 |
| 2024/11/28 | 4,615 | 4,664 | 4,593 | 4,662 | +44 | +1% | 911,400 |
| 2024/11/27 | 4,608 | 4,638 | 4,600 | 4,618 | -1 | ±0% | 869,400 |
| 2024/11/26 | 4,675 | 4,690 | 4,562 | 4,619 | -34 | -0.7% | 1,600,300 |
| 2024/11/25 | 4,665 | 4,708 | 4,636 | 4,653 | +3 | +0.1% | 1,698,700 |
| 2024/11/22 | 4,634 | 4,690 | 4,624 | 4,650 | +31 | +0.7% | 1,342,900 |
| 2024/11/21 | 4,635 | 4,678 | 4,618 | 4,619 | -26 | -0.6% | 1,717,000 |
| 2024/11/20 | 4,720 | 4,745 | 4,630 | 4,645 | -105 | -2.2% | 1,946,800 |
| 2024/11/19 | 4,826 | 4,857 | 4,750 | 4,750 | -34 | -0.7% | 1,804,100 |
| 2024/11/18 | 4,940 | 4,956 | 4,772 | 4,784 | -245 | -4.9% | 2,874,000 |
| 2024/11/15 | 5,080 | 5,100 | 5,029 | 5,029 | +72 | +1.5% | 1,850,600 |
| 2024/11/14 | 5,077 | 5,088 | 4,939 | 4,957 | -101 | -2% | 1,840,000 |
| 2024/11/13 | 5,055 | 5,123 | 5,030 | 5,058 | -11 | -0.2% | 1,631,200 |
| 2024/11/12 | 5,090 | 5,190 | 5,058 | 5,069 | +7 | +0.1% | 1,588,100 |
| 2024/11/11 | 5,100 | 5,108 | 4,983 | 5,062 | -14 | -0.3% | 2,218,100 |
| 2024/11/08 | 5,094 | 5,208 | 5,047 | 5,076 | +29 | +0.6% | 2,678,200 |
| 2024/11/07 | 5,074 | 5,129 | 5,026 | 5,047 | -11 | -0.2% | 1,445,700 |
| 2024/11/06 | 5,060 | 5,103 | 5,033 | 5,058 | +4 | +0.1% | 1,326,800 |
| 2024/11/05 | 5,070 | 5,078 | 5,031 | 5,054 | -21 | -0.4% | 1,379,500 |
51～
100
件表示中 / 3672件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| エーザイ | 390,500円 | +1.7% | -2.9% | 4.10% | 25.62倍 | 1.34倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| アステラス薬 | 137,500円 | +18.5% | -96.0% | 5.38% | 175.83倍 | 1.61倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 226,700円 | +5.7% | +3.9% | 2.53% | 11.27倍 | 1.49倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| 協和キリン | 211,900円 | -3.5% | -11.3% | 2.83% | 19.45倍 | 1.30倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| 小野薬 | 156,700円 | -3.5% | -50.2% | 5.11% | 12.69倍 | 0.95倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
